Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
The return on invested capital (ROIC) is -116.89% as of the fiscal period ended Tuesday, June 30, 2026.
Trailing-twelve-month return on invested capital at each fiscal quarter end; no daily interpolation.
Limited quarterly history available
ROIC needs at least three reported quarters before a meaningful chart is shown.
RETURN ON INVESTED CAPITAL (ROIC)
-116.89%
RETURN ON INVESTED CAPITAL (ROIC) AVG TTM
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 3Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 5Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 10Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 15Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-27.33%
median of 440 covered companies
CURRENT VS SECTOR MEDIAN
-327.70%
vs the sector median at left
20/20 Biolabs Inc.
Market Cap
$4.32M
Return on Invested Capital (ROIC)
-116.89%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$4.41M
Return on Invested Capital (ROIC)
-346.94%
TTM Avg
-467.60%
3Y Avg
-296.93%
5Y Avg
-277.74%
Market Cap
$4.42M
Return on Invested Capital (ROIC)
-221.32%
TTM Avg
-119.11%
3Y Avg
-77.97%
5Y Avg
-64.48%
Market Cap
$4.18M
Return on Invested Capital (ROIC)
N/A
TTM Avg
-199.78%
3Y Avg
-1598.70%
5Y Avg
-1598.70%
Market Cap
$4.46M
Return on Invested Capital (ROIC)
-246.61%
TTM Avg
-463.24%
3Y Avg
-303.42%
5Y Avg
-359.05%
Market Cap
$3.94M
Return on Invested Capital (ROIC)
-288.14%
TTM Avg
-190.86%
3Y Avg
-162.44%
5Y Avg
-129.35%
Market Cap
$4.79M
Return on Invested Capital (ROIC)
-38.23%
TTM Avg
-122.97%
3Y Avg
-1403.32%
5Y Avg
-860.06%
Market Cap
$4.85M
Return on Invested Capital (ROIC)
-122.56%
TTM Avg
-179.66%
3Y Avg
-275.36%
5Y Avg
-182.57%
Market Cap
$4.96M
Return on Invested Capital (ROIC)
-35.07%
TTM Avg
-9.54%
3Y Avg
2.54%
5Y Avg
2.54%
| NAME | MARKET CAP | RETURN ON INVESTED CAPITAL (ROIC) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| 20/20 Biolabs Inc. (AIDX) | $4.32M | -116.89% | N/A | N/A | N/A |
| Ernexa Therapeutics Inc. (ERNA)vs › | $4.41M | -346.94% | -467.60% | -296.93% | -277.74% |
| CollPlant Biotechnologies Ltd. (CLGN)vs › | $4.42M | -221.32% | -119.11% | -77.97% | -64.48% |
| GRI Bio, Inc. (GRI)vs › | $4.18M | N/A | -199.78% | -1598.70% | -1598.70% |
| Dermata Therapeutics, Inc. (DRMA)vs › | $4.46M | -246.61% | -463.24% | -303.42% | -359.05% |
| Aptevo Therapeutics Inc. (APVO)vs › | $3.94M | -288.14% | -190.86% | -162.44% | -129.35% |
| Bio Green Med Solution, Inc. (BGMS)vs › | $4.79M | -38.23% | -122.97% | -1403.32% | -860.06% |
| CalciMedica, Inc. (CALC)vs › | $4.85M | -122.56% | -179.66% | -275.36% | -182.57% |
| Basel Medical Group Ltd Ordinary Shares (BMGL)vs › | $4.96M | -35.07% | -9.54% | 2.54% | 2.54% |
| Gelteq Limited Ordinary Shares (GELS)vs › | $4.99M | -27.41% | -21.46% | -17.98% | -12.44% |
ROIC
-116.9%
ROE
-184.0%
ROIC = NOPAT / Invested Capital, where NOPAT = Operating Income × (1 − effective tax rate) and Invested Capital = Total Assets − (Current Liabilities − Short-Term Debt)
Return on invested capital measures the after-tax operating return a company earns on the capital invested in the business. TGMCharts computes it from reported statements: trailing-twelve-month operating income after tax, over invested capital at the latest balance sheet — total assets less the non-interest-bearing current liabilities (payables, accruals, deferred revenue) that fund them; short-term debt stays in the capital base. The tax rate is the period's own effective rate (income tax ÷ pretax income), capped at 45%; when pretax income is zero or negative, or the tax line is a net benefit, no tax is deducted — the operating figure is shown untaxed rather than adjusted by an assumed rate. Not shown for banks, insurers or funds.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON INVESTED CAPITAL (ROIC) |
|---|---|
| 2026-06-30 | -116.89% |